Thank you
HCPs are more digitally savvy now than ever. However, digital engagement with pharmaceutical companies and their representatives remains elusive. There is a need to understand HCP content and channel preferences and their evolving needs to ensure successful delivery of relevant content, but these preferences often vary at a regional, experience and specialty level which is a critical input for communications planning.
This ISMPP U will highlight the different preferences of HCPs for pharma engagement and how to appeal to HCPs around the world in an effective and efficient manner.
Learning objectives:
- Understanding a HCP’s perspective on how the COVID-19 pandemic has changed their consumption habits and the challenges faced
- Understanding strategies which the industry can utilise to keep up with changing HCP interaction trends
![](https://bluesky_portal_prod.s3.amazonaws.com/uploads/redactor_images/1623344609.049122_CMPP_credential.jpg)
Description
HCPs are more digitally savvy now than ever. However,
digital engagement with pharmaceutical companies and their representatives
remains elusive. There is a need to understand HCP content and channel
preferences and their evolving needs to ensure successful delivery of relevant
content, but these preferences often vary at a regional, experience and
specialty level which is a critical input for communications planning.
This ISMPP U will highlight the different preferences of
HCPs for pharma engagement and how to appeal to HCPs around the world in an
effective and efficient manner.
Learning objectives:
- Understanding a HCP’s perspective on how the COVID-19 pandemic has changed their consumption habits and the challenges faced
- Understanding strategies which the industry can utilise to keep up with changing HCP interaction trends
![](https://bluesky_portal_prod.s3.amazonaws.com/uploads/redactor_images/1623344609.049122_CMPP_credential.jpg)